137 related articles for article (PubMed ID: 12605970)
1. Do dose-volume metrics predict pulmonary function changes in lung irradiation?
Allen AM; Henning GT; Ten Haken RK; Hayman JA; Martel MK
Int J Radiat Oncol Biol Phys; 2003 Mar; 55(4):921-9. PubMed ID: 12605970
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary function following high-dose radiotherapy of non-small-cell lung cancer.
De Jaeger K; Seppenwoolde Y; Boersma LJ; Muller SH; Baas P; Belderbos JS; Lebesque JV
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1331-40. PubMed ID: 12654445
[TBL] [Abstract][Full Text] [Related]
3. Physical and biological predictors of changes in whole-lung function following thoracic irradiation.
Marks LB; Munley MT; Bentel GC; Zhou SM; Hollis D; Scarfone C; Sibley GS; Kong FM; Jirtle R; Jaszczak R; Coleman RE; Tapson V; Anscher M
Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):563-70. PubMed ID: 9336133
[TBL] [Abstract][Full Text] [Related]
4. Should regional ventilation function be considered during radiation treatment planning to prevent radiation-induced complications?
Lan F; Jeudy J; Senan S; van Sornsen de Koste JR; D'Souza W; Tseng HH; Zhou J; Zhang H
Med Phys; 2016 Sep; 43(9):5072. PubMed ID: 27587037
[TBL] [Abstract][Full Text] [Related]
5. Lack of a dose-effect relationship for pulmonary function changes after stereotactic body radiation therapy for early-stage non-small cell lung cancer.
Guckenberger M; Klement RJ; Kestin LL; Hope AJ; Belderbos J; Werner-Wasik M; Yan D; Sonke JJ; Bissonnette JP; Xiao Y; Grills IS
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):1074-81. PubMed ID: 23154077
[TBL] [Abstract][Full Text] [Related]
6. Evaluating Which Dose-Function Metrics Are Most Critical for Functional-Guided Radiation Therapy.
Faught AM; Yamamoto T; Castillo R; Castillo E; Zhang J; Miften M; Vinogradskiy Y
Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):202-209. PubMed ID: 28816147
[TBL] [Abstract][Full Text] [Related]
7. Three-dimensional conformal radiation therapy for non-small-cell lung cancer: a phase I/II dose escalation clinical trial.
Wu KL; Jiang GL; Liao Y; Qian H; Wang LJ; Fu XL; Zhao S
Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1336-44. PubMed ID: 14630271
[TBL] [Abstract][Full Text] [Related]
8. Prediction of overall pulmonary function loss in relation to the 3-D dose distribution for patients with breast cancer and malignant lymphoma.
Theuws JC; Kwa SL; Wagenaar AC; Seppenwoolde Y; Boersma LJ; Damen EM; Muller SH; Baas P; Lebesque JV
Radiother Oncol; 1998 Dec; 49(3):233-43. PubMed ID: 10075256
[TBL] [Abstract][Full Text] [Related]
9. Prediction of radiation pneumonitis: dose-volume histogram analysis in 62 patients with non-small cell lung cancer after three-dimensional conformal radiotherapy.
Piotrowski T; Matecka-Nowak M; Milecki P
Neoplasma; 2005; 52(1):56-62. PubMed ID: 15739028
[TBL] [Abstract][Full Text] [Related]
10. Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer.
Murshed H; Liu HH; Liao Z; Barker JL; Wang X; Tucker SL; Chandra A; Guerrero T; Stevens C; Chang JY; Jeter M; Cox JD; Komaki R; Mohan R
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1258-67. PubMed ID: 15001271
[TBL] [Abstract][Full Text] [Related]
11. Radiation pneumonitis and pulmonary fibrosis in non-small-cell lung cancer: pulmonary function, prediction, and prevention.
Mehta V
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):5-24. PubMed ID: 15963660
[TBL] [Abstract][Full Text] [Related]
12. Results of a phase I dose-escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinoma.
Rosenzweig KE; Fox JL; Yorke E; Amols H; Jackson A; Rusch V; Kris MG; Ling CC; Leibel SA
Cancer; 2005 May; 103(10):2118-27. PubMed ID: 15830346
[TBL] [Abstract][Full Text] [Related]
13. Radiation pneumonitis following treatment of non-small-cell lung cancer with continuous hyperfractionated accelerated radiotherapy (CHART).
Jenkins P; D'Amico K; Benstead K; Elyan S
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):360-6. PubMed ID: 12738310
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy for lung cancer: target splitting by asymmetric collimation enables reduction of radiation doses to normal tissues and dose escalation.
Wurstbauer K; Deutschmann H; Kranzinger M; Merz F; Rahim H; Sedlmayer F; Kogelnik HD
Int J Radiat Oncol Biol Phys; 1999 May; 44(2):333-41. PubMed ID: 10760428
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary function changes after radiotherapy in non-small-cell lung cancer patients with long-term disease-free survival.
Borst GR; De Jaeger K; Belderbos JS; Burgers SA; Lebesque JV
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):639-44. PubMed ID: 15936539
[TBL] [Abstract][Full Text] [Related]
16. The relationship between local dose and loss of function for irradiated lung.
Gopal R; Tucker SL; Komaki R; Liao Z; Forster KM; Stevens C; Kelly JF; Starkschall G
Int J Radiat Oncol Biol Phys; 2003 May; 56(1):106-13. PubMed ID: 12694828
[TBL] [Abstract][Full Text] [Related]
17. Changes in pulmonary function after three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, or proton beam therapy for non-small-cell lung cancer.
Lopez Guerra JL; Gomez DR; Zhuang Y; Levy LB; Eapen G; Liu H; Mohan R; Komaki R; Cox JD; Liao Z
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e537-43. PubMed ID: 22420964
[TBL] [Abstract][Full Text] [Related]
18. Adding ipsilateral V20 and V30 to conventional dosimetric constraints predicts radiation pneumonitis in stage IIIA-B NSCLC treated with combined-modality therapy.
Ramella S; Trodella L; Mineo TC; Pompeo E; Stimato G; Gaudino D; Valentini V; Cellini F; Ciresa M; Fiore M; Piermattei A; Russo P; Cesario A; D'Angelillo RM
Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):110-5. PubMed ID: 19619955
[TBL] [Abstract][Full Text] [Related]
19. Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study.
Yorke ED; Jackson A; Rosenzweig KE; Braban L; Leibel SA; Ling CC
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):672-82. PubMed ID: 15939548
[TBL] [Abstract][Full Text] [Related]
20. Toxicity and outcome results of a class solution with moderately hypofractionated radiotherapy in inoperable Stage III non-small cell lung cancer using helical tomotherapy.
Bral S; Duchateau M; Versmessen H; Engels B; Tournel K; Vinh-Hung V; De Ridder M; Schallier D; Storme G
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1352-9. PubMed ID: 20056350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
